Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 878 across all filing types
Latest filing 2019-11-24 Regulatory Filings
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Adherium CEO Presentation to AGM 15 pages 4.9MB
Regulatory Filings
2019-11-24 English
Results of Meeting 2 pages 287.7KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF ANNUAL GENERAL MEETING' and provides detailed voting results for resolutions passed at the Adherium Limited 2019 Annual General Meeting held on 25 November 2019. It includes proxy votes, votes for and against, and whether each resolution was carried or not. The content is focused on the official announcement of voting outcomes from the AGM, not the AGM materials or presentations themselves. The document length is 4726 characters, which is relatively short and consistent with a voting results announcement rather than a full AGM report or presentation. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-11-24 English
Adherium appoints Peter Stratford CEO and Mike Motion CCO 3 pages 171.4KB
Board/Management Information Classification · 95% confidence The document announces the appointment of a new CEO and Chief Commercial Officer at Adherium Limited, detailing their backgrounds and contractual terms. It focuses on management changes and executive appointments rather than financial results, regulatory filings, or shareholder votes. There is no indication of financial data, audit information, or report publication. The content aligns with announcements about changes in senior management.
2019-11-21 English
Adherium and Patients Know Best strategic collaboration 2 pages 131.1KB
Regulatory Filings Classification · 90% confidence The document is a press release announcing a strategic collaboration between Adherium and Patients Know Best in the UK to support NHS commercialization. It discusses the integration of health platforms and the potential economic benefits to the NHS. There is no indication of financial data, regulatory filings, management changes, or any formal report or filing type. The content is primarily a corporate announcement about a partnership and product integration, not a financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2019-11-17 English
Adherium announces $1.2m second round notes financing 1
Capital/Financing Update Classification · 100% confidence The document is an announcement about a $1.2 million second round secured notes financing by Adherium Limited. It discusses the details of the financing, the investors involved, and the intended use of funds. There is no financial statement, comprehensive financial data, or detailed report content. The document is relatively short (2947 characters) and serves as an update on capital raising activities. Therefore, it fits the category of Capital/Financing Update (CAP).
2019-11-10 English
Response to ASX Query 4 pages 662.8KB
Regulatory Filings Classification · 95% confidence The document is a response letter from Adherium Limited to the ASX (Australian Securities Exchange) regarding a query letter dated 4 November 2019. The ASX query concerns the company's Appendix 4C quarterly report for the period ended 30 September 2019, specifically about negative operating cash flows and the company's ability to continue funding operations. The letter addresses questions about cash flow, financing steps, compliance with listing rules, and confirmation of authorization for the responses. The document is a regulatory compliance communication responding to an ASX request under Listing Rule 18.7, not the actual Appendix 4C report or a financial report itself. It contains no substantive financial statements or detailed financial analysis but rather explanations and confirmations related to regulatory disclosure requirements. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2019-11-10 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.